CDKN2A and coronary artery disorder: Despite potential functionality in endothelial cells, research also implicates VSMCs with a role in CAD pathogenesis, with an early study demonstrating differential expression of CDKN2A/CDKN2B/CDKN2B-AS1 in these cells [54].